BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24566695)

  • 1. [Hungarian national plan and strategy for rare diseases].
    Kosztolányi G
    Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rare diseases and their patient organization: the Hungarian Federation of People with Rare and Congenital Diseases].
    Pogány G
    Orv Hetil; 2014 Mar; 155(9):329-33. PubMed ID: 24566696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Union Policy in the Field of Rare Diseases.
    Moliner AM; Waligora J
    Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a European Union framework for actions in the field of rare diseases.
    Moliner AM
    Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European union policy in the field of rare diseases.
    Montserrat Moliner A; Waligóra J
    Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The actual questions of the care of rare diseases].
    Pogány G
    Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of 11 national policies for rare diseases in the context of key patient needs.
    Dharssi S; Wong-Rieger D; Harold M; Terry S
    Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National plans and strategies on rare diseases in Europe.
    Taruscio D; Vittozzi L; Stefanov R
    Adv Exp Med Biol; 2010; 686():475-91. PubMed ID: 20824461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [E-health developments in the system of health services in Hungary and the European Union].
    Váradi Á
    Orv Hetil; 2014 May; 155(21):822-7. PubMed ID: 24836317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUROPLAN: a project to support the development of national plans on rare diseases in Europe.
    Taruscio D; Gentile AE; De Santis M; Ferrelli RM; Posada de la Paz M; Hens M; Huizer J; Fregonese L; Stefanov R; Bottarelli V; Weinman A; Le Cam Y; Gavhed D; Mincarone P; Bushby K; Frazzica RG; Donati C; Vittozzi L; Jessop E
    Public Health Genomics; 2013; 16(6):278-87. PubMed ID: 24503588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].
    Frank M; Eidt-Koch D; Aumann I; Reimann A; Wagner TO; Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1216-23. PubMed ID: 25209683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Editor's commentary. Rare diseases in Hungary].
    Oláh E
    Orv Hetil; 2014 Mar; 155(9):323-4. PubMed ID: 24566694
    [No Abstract]   [Full Text] [Related]  

  • 16. How the EUCERD Joint Action supported initiatives on Rare Diseases.
    Lynn S; Hedley V; Atalaia A; Evangelista T; Bushby K;
    Eur J Med Genet; 2017 Mar; 60(3):185-189. PubMed ID: 28087401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for rare diseases: mixed assessment in Europe.
    Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
    Liu BC; He L; He G; He Y
    J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hungarian psychiatry in the light of the Hungarian Presidency of the Council of the European Union].
    Kurimay T
    Psychiatr Hung; 2010; 25(6):483-92. PubMed ID: 21300996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [European Reference Networks : Consequences for healthcare in Germany].
    Graessner H; Schäfer F; Scarpa M; Wagner TOF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.